High-Dose Pemetrexed in Combination with High-Dose Crizotinib for the Treatment of Refractory CNS Metastases in ALK-Rearranged Non-Small-Cell Lung Cancer

被引：32
作者：
Gandhi, Leena [1 ,2 ,3 ]
Drappatz, Jan [5 ,6 ]
Ramaiya, Nikhil H. [3 ]
Otterson, Gregory A. [4 ]
机构：
[1] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Med Oncol, Boston, MA 02215 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02215 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02215 USA
[4] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[5] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[6] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷 / 01期
关键词：
D O I：
10.1097/JTO.0b013e3182762d20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E3 / E5
页数：3
相关论文
共 8 条
  • [1] Administration. UFaD, FDA LAB INF XALK
  • [2] Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer
    Bearz, Alessandra
    Garassino, Isabella
    Tiseo, Marcello
    Caffo, Orazio
    Soto-Parra, Hector
    Boccalon, Massimo
    Talamini, Renato
    Santoro, Armando
    Bartolotti, Marco
    Murgia, Viviana
    Berretta, Massimiliano
    Tirelli, Umberto
    [J]. LUNG CANCER, 2010, 68 (02) : 264 - 268
  • [3] Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed
    Camidge, D. Ross
    Kono, Scott A.
    Lu, Xian
    Okuyama, Sonia
    Baron, Anna E.
    Oton, Ana B.
    Davies, Angela M.
    Varella-Garcia, Marileila
    Franklin, Wilbur
    Doebele, Robert C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (04) : 774 - 780
  • [4] CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib
    Costa, Daniel B.
    Kobayashi, Susumu
    Pandya, Shuchi S.
    Yeo, Wee-Lee
    Shen, Zhongzhou
    Tan, Weiwei
    Wilner, Keith D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : E443 - E445
  • [5] A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
    Cullen, M. H.
    Zatloukal, P.
    Sorenson, S.
    Novello, S.
    Fischer, J. R.
    Joy, A. A.
    Zereu, M.
    Peterson, P.
    Visseren-Grul, C. M.
    Iscoe, N.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (05) : 939 - 945
  • [6] Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer
    Lee, Jeong-Ok
    Kim, Tae Min
    Lee, Se-Hoon
    Kim, Dong-Wan
    Kim, Soyeon
    Jeon, Yoon-Kyung
    Chung, Doo Hyun
    Kim, Woo-Ho
    Kim, Young Tae
    Yang, Seok-Chul
    Kim, Young Whan
    Heo, Dae Seog
    Bang, Yung-Jue
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1474 - 1480
  • [7] Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma
    Raizer, Jeffrey J.
    Rademaker, Alfred
    Evens, Andrew M.
    Rice, Laurie
    Schwartz, Margaret
    Chandler, James P.
    Getch, Christopher C.
    Tellez, Claudia
    Grimm, Sean A.
    [J]. CANCER, 2012, 118 (15) : 3743 - 3748
  • [8] Shaw AT, 2012, ANN ONCOL
1